These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 1738127

  • 1. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF, De Clerck F, Lefort J, Arreto CD, Vargaftig BB.
    J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
    [Abstract] [Full Text] [Related]

  • 2. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
    Weber C, Beetens JR, Tegtmeier F, Van Rooy P, Vercammen E, Wouters L, De Clerck F.
    Thromb Haemost; 1992 Aug 03; 68(2):214-20. PubMed ID: 1412169
    [Abstract] [Full Text] [Related]

  • 3. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R, Nenci GG, Gresele P.
    J Pharmacol Exp Ther; 1995 Dec 03; 275(3):1497-505. PubMed ID: 8531121
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 03; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 5. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J, Mehta P, Lawson DL, Ostrowski N, Brigmon L.
    J Lab Clin Med; 1985 Sep 03; 106(3):246-52. PubMed ID: 3928780
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.
    Boukili MA, Bureau M, Lagente V, Lefort J, Lellouch-Tubiana A, Malanchère E, Vargaftig BB.
    Br J Pharmacol; 1986 Oct 03; 89(2):349-59. PubMed ID: 3096407
    [Abstract] [Full Text] [Related]

  • 7. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.
    Ciabattoni G, Montuschi P, Currò D, Togna G, Preziosi P.
    Br J Pharmacol; 1993 May 03; 109(1):243-50. PubMed ID: 8495242
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F, Colombo M, Pierucci L, Volpi D, Dho L, Ukmar G, Rosa B, Salvati P.
    Drugs Exp Clin Res; 1993 May 03; 19(6):249-60. PubMed ID: 8013268
    [Abstract] [Full Text] [Related]

  • 9. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C, Rousselot C, Chavernac G, Depin JC, Guerrier D.
    Arzneimittelforschung; 1994 Nov 03; 44(11):1196-202. PubMed ID: 7848331
    [Abstract] [Full Text] [Related]

  • 10. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
    De Clerck F, Beetens J, de Chaffoy de Courcelles D, Freyne E, Janssen PA.
    Thromb Haemost; 1989 Feb 28; 61(1):35-42. PubMed ID: 2546278
    [Abstract] [Full Text] [Related]

  • 11. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D, De Clerck F.
    Eur J Pharmacol; 1990 Mar 13; 188(2-3):161-9. PubMed ID: 2318257
    [Abstract] [Full Text] [Related]

  • 12. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU, Heinroth I, Giessler C, Pönicke K, Mentz P, Zehl U, Rettkowski W, Dunemann A, Förster W.
    Biomed Biochim Acta; 1983 Mar 13; 42(2-3):283-99. PubMed ID: 6411078
    [Abstract] [Full Text] [Related]

  • 13. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J, Thaulow E, Myhre E, Parry J.
    Thromb Haemost; 1983 Oct 31; 50(3):703-6. PubMed ID: 6689091
    [Abstract] [Full Text] [Related]

  • 14. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
    Horn EH, Hardy E, Cooper J, Heptinstall S, Rubin PC.
    Thromb Haemost; 1996 Feb 31; 75(2):346-51. PubMed ID: 8815588
    [Abstract] [Full Text] [Related]

  • 15. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.
    De Clerck F, Beetens J, Van de Water A, Vercammen E, Janssen PA.
    Thromb Haemost; 1989 Feb 28; 61(1):43-9. PubMed ID: 2526385
    [Abstract] [Full Text] [Related]

  • 16. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I, Block HU, Mest HJ.
    Biomed Biochim Acta; 1984 Feb 28; 43(8-9):S389-92. PubMed ID: 6440555
    [Abstract] [Full Text] [Related]

  • 17. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A, Navran SS, Amin HM, Abdel-Aziz SA, Chang J, Sober DJ, Miller DD, Feller DR.
    J Pharmacol Exp Ther; 1985 Jan 28; 232(1):1-9. PubMed ID: 3855323
    [Abstract] [Full Text] [Related]

  • 18. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries.
    Bourgain RH, Andries R, Decuyper K, De Clerck F.
    J Lipid Mediat; 1991 Jan 28; 3(1):3-11. PubMed ID: 1837488
    [Abstract] [Full Text] [Related]

  • 19. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P, Giordani A, Menichincheri M, Pillan A, Pinciroli V, Rossi A, Tonani R, Volpi D, Tamburin M, Ferrario R.
    J Med Chem; 1994 Oct 14; 37(21):3588-604. PubMed ID: 7932586
    [Abstract] [Full Text] [Related]

  • 20. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW, Morton HE, Fortin R, Yoakim C, Girard Y, Lord A, Ethier D, Leveille C, Letts G, Evans J.
    Prog Clin Biol Res; 1989 Oct 14; 301():579-83. PubMed ID: 2529557
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.